Clinical Trial Update: Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 pilot trial evaluated adding olanzapine and aprepitant to standard antiemetic therapy to prevent nausea and vomiting in pediatric patients receivin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• olanzapine (olanzapine)

Snippet

Sponsor: Indiana University | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2017-03-30